Apellis Pharmaceuticals (APLS) PT Lowered to $55 at Baird
Tweet Send to a Friend
(Updated - November 7, 2024 7:13 AM EST)
Baird analyst Colleen Kusy lowered the price target on Apellis Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird analyst Colleen Kusy lowered the price target on Apellis Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
